Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D03FVR
|
||||
| Former ID |
DIB012008
|
||||
| Drug Name |
GSK-1827771
|
||||
| Synonyms |
IL-1 antagonist (antibody, rheumatoid arthritis), GSK
|
||||
| Drug Type |
Antibody
|
||||
| Indication | Rheumatoid arthritis [ICD9: 710-719, 714; ICD10:M05-M06] | Phase 1 | [522135] | ||
| Company |
GlaxoSmithKline plc
|
||||
| Target and Pathway | |||||
| Target(s) | Interleukin-1 receptor, type II | Target Info | [550163] | ||
| NetPath Pathway | IL1 Signaling Pathway | ||||
| TNFalpha Signaling Pathway | |||||
| Pathway Interaction Database | IL1-mediated signaling events | ||||
| Reactome | Interleukin-1 signaling | ||||
| References | |||||